Geneos Wealth Management’s Morgan Stanley Pathway Small-Mid Cap Equity ETF MSSM Stock Holding History
Bought
Maintained
Sold
Other funds holding MSSM
APW
AA
TCOV
Geneos Wealth Management's MSSM Position: Q4 2025 in Review
Geneos Wealth Management sold out of Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) in Q4 2025, closing a stake of 32 shares — an estimated $1.63K sold.
Geneos Wealth Management first reported a position in MSSM in Q1 2025 and held it in 3 quarters. The position peaked at $2.76K in Q1 2025. 17 funds tracked by Wall St. Rank hold MSSM as of Q4 2025.
- Geneos Wealth Management reported no remaining Morgan Stanley Pathway Small-Mid Cap Equity ETF position as of Q4 2025 after selling out during the quarter.
- Geneos Wealth Management sold 32 Morgan Stanley Pathway Small-Mid Cap Equity ETF shares in Q4 2025, an estimated $1.63K.
- Geneos Wealth Management first reported a position in Morgan Stanley Pathway Small-Mid Cap Equity ETF in Q1 2025 and held it in 3 quarters.
- Geneos Wealth Management's Morgan Stanley Pathway Small-Mid Cap Equity ETF position peaked at $2.76K in Q1 2025.
- 17 funds tracked by Wall St. Rank held Morgan Stanley Pathway Small-Mid Cap Equity ETF as of Q4 2025.
Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.